Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Clinical Trial

Research Support, N.I.H., Extramural

Research Support, U.S. Gov't, P.H.S.

Multicenter Study

Controlled Clinical Trial

Research Support, U.S. Gov't, Non-P.H.S.

Review

Comparative Study

Meta-Analysis

Systematic Review

Twin Study

Publication Year

From

Quick links

Individual year

2025

2024

2022

2021

2020

2017

2016

2015

2014

2013

2011

2010

2009

2008

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Apolipoprotein A-II""[mesh_terms]

42 Results

Searching titles within these results

Resolution of apolipoprotein A1 and A2 proteoforms: their cardiometabolic correlates and implications for future research.

Anand Rohatgi, John T Wilkins

Current opinion in lipidology 2022;33(4):264-269

Free Full Text

Abstract

Apolipoprotein A-I, A-II, and VLDL-B-100 metabolism in men: comparison of a low-fat diet and a high-monounsaturated fatty acid diet.

Sophie Desroches, Marie-Eve Paradis, Mélanie Pérusse, W Roodly Archer, Jean Bergeron, Patrick Couture, Nathalie Bergeron, Benoît Lamarche

Journal of lipid research 2005;45(12):2331-8

Free Full Text

Abstract

Omega-3 Fatty Acids Effects on Inflammatory Biomarkers and Lipid Profiles among Diabetic and Cardiovascular Disease Patients: A Systematic Review and Meta-Analysis.

Zuhair S Natto, Thomas E Van Dyke, Heba K Alshaeri, Wael Yaghmoor

Scientific reports 2021;9(1):18867

Free Full Text

Abstract

HDL: bridging past and present with a look at the future.

Angelo M Scanu, Celina Edelstein

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(12):4044-54

Free Full Text

Abstract

Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [(2)H(3)]leucine in middle-aged and elderly men and women.

W Velez-Carrasco, A H Lichtenstein, Z Li, G G Dolnikowski, S Lamon-Fava, F K Welty, E J Schaefer

Arteriosclerosis, thrombosis, and vascular biology 2000;20(3):801-6

Full Text

Abstract

Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism.

Margaret E Brousseau, John S Millar, Margaret R Diffenderfer, Chorthip Nartsupha, Bela F Asztalos, Megan L Wolfe, James P Mancuso, Andres G Digenio, Daniel J Rader, Ernst J Schaefer

Journal of lipid research 2009;50(7):1456-62

Free Full Text

Abstract

Effect of moderate alcohol intake on blood apolipoproteins concentrations: A meta-analysis of human intervention studies.

Trine Levring Wilkens, Lars Ove Dragsted, Gabriele Berg-Beckhoff, Anila Khatiwada, Sine Højlund Christensen, Anju Rawal

Nutrition, metabolism, and cardiovascular diseases : NMCD 2025;35(7):103854

Full Text

Abstract

High-density lipoprotein synthesis and metabolism (Review).

Lingyan Zhou, Congcong Li, Ling Gao, Aihong Wang

Molecular medicine reports 2016;12(3):4015-4021

Full Text

Abstract

The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy.

B G A Stuckey, P H R Barrett, J M Wagner, R A Hampton, D C Chan, S J Brown, G F Watts

Clinical endocrinology 2011;73(4):497-501

Full Text

Abstract

Xanthophylls, phytosterols and pre-β1-HDL are differentially affected by fenofibrate and niacin HDL-raising in a cross-over study.

Eric J Niesor, Renee Benghozi, Simona Rossomanno, Elisabetta Damonte, Bela Asztalos, Gabriela Suchankova, R A Gangani D Silva, Kekulawalage Gauthamadasa, Markus Abt, W Sean Davidson, David Kallend, Helena Gylling

Lipids 2014;48(12):1185-96

Full Text

Abstract

Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL.

Daniel J Rader, Philippe O Szapary, Megan L Wolfe, LeAnne T Bloedon, Katsunori Ikewaki, John S Millar

Journal of lipid research 2011;52(1):136-42

Free Full Text

Abstract

Differential weight-loss responses of APOA2 genotype carriers to low-carbohydrate and low-fat diets: the DIETFITS trial.

Christopher D Gardner, José M Ordovás, Sai Krupa Das, Laurence D Parnell, Chao-Qiang Lai

Obesity (Silver Spring, Md.) 2025;33(6):1048-1057

Full Text

Abstract

Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol.

T Sakai, V S Kamanna, M L Kashyap

Arteriosclerosis, thrombosis, and vascular biology 2001;21(11):1783-9

Full Text

Abstract

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.

Gerald F Watts, P Hugh R Barrett, Dick C Chan, Theodore W K Ng

Clinical science (London, England : 1979) 2009;118(1):79-85

Free Full Text

Abstract

Lipoprotein metabolism in subjects with hepatic lipase deficiency.

Marju Tilly-Kiesi, Ernst J Schaefer, Petteri Knudsen, Francine K Welty, Gregory G Dolnikowski, Marja-Riitta Taskinen, Alice H Lichtenstein

Metabolism: clinical and experimental 2004;53(4):520-5

Full Text

Abstract

Results: 1 – 15 / 42

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Apolipoprotein A-II""[mesh_terms]

Resolution of apolipoprotein A1 and A2 proteoforms: their cardiometabolic correlates and implications for future research.

Apolipoprotein A-I, A-II, and VLDL-B-100 metabolism in men: comparison of a low-fat diet and a high-monounsaturated fatty acid diet.

Omega-3 Fatty Acids Effects on Inflammatory Biomarkers and Lipid Profiles among Diabetic and Cardiovascular Disease Patients: A Systematic Review and Meta-Analysis.

HDL: bridging past and present with a look at the future.

Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [(2)H(3)]leucine in middle-aged and elderly men and women.

Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism.

Effect of moderate alcohol intake on blood apolipoproteins concentrations: A meta-analysis of human intervention studies.

High-density lipoprotein synthesis and metabolism (Review).

The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy.

Xanthophylls, phytosterols and pre-β1-HDL are differentially affected by fenofibrate and niacin HDL-raising in a cross-over study.

Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL.

Differential weight-loss responses of APOA2 genotype carriers to low-carbohydrate and low-fat diets: the DIETFITS trial.

Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol.

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.

Lipoprotein metabolism in subjects with hepatic lipase deficiency.

Results for
""Apolipoprotein A-II""[mesh_terms]